REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
Synthetic Control Arms: When Data Stands In For Patients
Synthetic control arms replace traditional control groups with carefully matched historical or real-world data, offering an option for rare diseases, ethical constraints, or when high-quality datasets exist. They can speed access to treatments, but success depends on rigorous data matching, upfront planning, and early regulatory engagement.
-
Is Double Programming Really Required For Validation?
Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
RWD/RWE RESOURCES
-
5 Key Takeaways From The FDA's Real-World Evidence Guidance
With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
Comprehensive Data Management For Non-Interventional Research
Learn how your teams can embrace end-to-end clinical trial data platforms for non-interventional studies to improve user experience, boost patient engagement, ensure data quality, and achieve study success.
-
How To Use Real World Data To Maximize Patient Recruitment In DCTs
In the clinical trial space, RWD helps support research design, protocol and patient engagement goals. Perhaps the most immediate way clinical research leaders can harness the power of RWD is as a tool for optimized patient recruitment. Learn how this can be done in the available blog.
-
CDW: An Evolving Product Category Speeds Access To Quality Data
Explore how exponential increases in third-party patient data have catalyzed the emergence of the clinical data workbench, representing a pivotal advancement in the evolving field of data management.
-
How Medidata Link Is Supporting Moderna's Clinical Trial Real-World Data Linkage Initiatives
Discover how Medidata Link empowers Moderna's clinical trial RWD linkage initiatives, enhancing insights into treatment outcomes while minimizing administrative burdens.
-
The Future Of Health Data: A 2022 Life Sciences Industry Insights Report
A survey of life sciences leaders reveals some of the key challenges that come with using real-world data (RWD) for innovation, along with their vision and predictions for how RWD can accelerate drug development and improve patient outcomes.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.